We've been told for years that Geert was not interested in making a partnership deal before Phase 3 was on the table. Maybe that made sense- to deal from a position of strength to get the most for the shareholders. But after Phase 3 was given the green light by the FDA, what kind of a deal did Geert work out? Another stinking screw-the-shareholders S-3 deal, where once yet again, the fine print offers the "partners" many more shares for their warrants, the lower the stock goes. It's like that TV commercial where the newest beast tells the maiden she was "just one kiss away".